| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 03/16/2005 | CN1594307A Extraction separation for Nepal irid isoflavone from kudzu, process for preparing sulfonated compounds thereof , and their pharmaceutical uses |
| 03/16/2005 | CN1594306A Genistein-3'-sodium sulfonate, dimethylation daidzein-3'-sodium sulfonate, their preparing process and pharmaceutical use |
| 03/16/2005 | CN1594305A Process for preparing scutellarin from baicalin |
| 03/16/2005 | CN1594304A Process for preparation of 7, 8-dihydrocoumarin included by cyclodextrin and its derivatives |
| 03/16/2005 | CN1594247A Yew genus plant extract and its extraction method and application |
| 03/16/2005 | CN1193023C Method for preparing alpha-tocopherol acetate |
| 03/15/2005 | US6867335 Carene epoxide intermediate that has been used as a precursor to tetrahydrocannabinoids |
| 03/15/2005 | US6867308 Process for separation of tocopherols |
| 03/15/2005 | US6867307 Intermediates for use in the preparation of vitamin E |
| 03/10/2005 | WO2005021496A2 Synthesis of derivatives of ginkgolide c |
| 03/10/2005 | WO2005021479A1 Benzotropolone derivatives and modulation of inflammatory response |
| 03/10/2005 | WO2005020981A1 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 03/10/2005 | WO2004098284A3 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives |
| 03/10/2005 | WO2002080150A8 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness |
| 03/10/2005 | US20050054717 Coumarin derivative |
| 03/10/2005 | US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 03/10/2005 | US20050054681 Coumarins as iNOS inhibitors |
| 03/10/2005 | US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders |
| 03/10/2005 | US20050051483 forskolin, isoforskolin or 7-deacetylforskolin complexing/solubilizing with cyclodextrin agent; ophthamology |
| 03/10/2005 | CA2536842A1 Benzotropolone derivatives and modulation of inflammatory response |
| 03/09/2005 | EP1511734A2 Compounds, compositions, and methods |
| 03/09/2005 | EP1137429B1 Cherry extracts for inhibiting cyclooxygenase enzymes |
| 03/09/2005 | CN1592745A Therapeutic chromone compounds |
| 03/09/2005 | CN1590385A Method of extracting soyabean isoflavone and soya bean saponin for soya bean whey waste water |
| 03/09/2005 | CN1192026C Process |
| 03/08/2005 | US6864377 Synthetic methods for preparing procyanidin oligomers |
| 03/08/2005 | US6864280 Hypotensive agents; cardiovascular disorders |
| 03/08/2005 | US6864279 2h-chromene derivatives metabolized both by cytochrome P450 and by a non-oxidative metabolic enzyme or system of enzymes; do not cause metabolic DDI when co-administered with other drugs |
| 03/08/2005 | US6863843 Naphthopyran compounds, photoresponsive compositions and lenses |
| 03/03/2005 | WO2005019197A1 Chromen-4-one derivatives |
| 03/03/2005 | WO2005003085A3 Tajixanthone hydrate and tajixanthone hydrate derivatives, biological activities thereof, and use thereof |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same |
| 03/03/2005 | US20050049298 pH controlled aqueous solvent extraction from plant material of carboxylic acid form; salt formation and extraction into organic solvent; decarboxylation; filtration and/or chromatographic purification |
| 03/03/2005 | US20050049284 therapeutic and preventive agents for scavenging free radicals and for inflammatory conditions; show a high safety even in a long-term administration and used as part of food, beverage and/or cosmetic products that are used daily; Neotheaflavate B; EGCGCa ( Epigallocatechinocatechol gallate ) |
| 03/03/2005 | US20050049272 Gastrointestinal disorders; inhibiting gastric acid secretion; such as 2,3-dimethyl-9-(2-ethyl-6-methyl-phenyl)-7H-8,9-dihydro-pyrano[2,3-c]-imidazo[1,2-a]pyridine-6-(N,N-diethyl)carbamide |
| 03/03/2005 | US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 03/03/2005 | US20050049238 Heterocyclic retinoid compounds |
| 03/03/2005 | US20050048149 Controlling weight, obesity; antidiabetic agents; using apple juice extract |
| 03/02/2005 | EP1509491A1 Intermediate products, methods for their preparation and use thereof |
| 03/02/2005 | EP1363894B1 Preparation of warfarin sodium from warfarin acid |
| 03/02/2005 | EP1294658B1 Process for the preparation of nitroalkenes |
| 03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1191244C Baicalein 8-position substituted methylamine like derivative and its preparation method |
| 03/02/2005 | CN1191232C Aminomethylcarboxylic acid derivatives |
| 02/24/2005 | WO2005017185A2 HEPATOCYTE NUCLEAR FACTOR 4α MODULATOR COMPOUNDS |
| 02/24/2005 | WO2005016907A1 Novel flavone derivatives, preparation method thereof and pharmaceutical compositions containing same |
| 02/24/2005 | WO2004094400A3 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 02/24/2005 | WO2004076438A3 Benzochromene derivatives |
| 02/24/2005 | US20050043411 Process for preparing homophthalate derivatives |
| 02/24/2005 | US20050043398 such as 2-ethoxycarbonyl-7-hydroxychromone, for the care, preservation or improvement of the general state of the skin or hair |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043350 Administering heterocyclic ether such as 5-chloro-7-hydroxy-3-(4-hydroxyphenylz)-4-oxo-1-benzopyran for prophylaxis of Alzheimer's disease, osteoporosis, cardiovascular disorders, psychological disorders, antiarthritic agents,anxiolytic agents |
| 02/24/2005 | US20050042662 For tracing/imaging molecular transfer between cellular gap junctions |
| 02/24/2005 | US20050042407 containing a cyanovinylene group; can be written on or read by blue light, preferably laser light |
| 02/24/2005 | US20050042318 Controlling hormone sensitive diseases; solvent extraction of hops, filtration, desolventizing |
| 02/23/2005 | EP1508327A1 Use of chromen-4-one derivatives for the care of skin and hair |
| 02/23/2005 | EP1507527A2 Methods for enhancing motor performance and/or endurance |
| 02/23/2005 | EP1407036A4 Flavonoid concentrates |
| 02/23/2005 | EP1119350B1 Rar antagonists as male anti-fertility agents |
| 02/23/2005 | EP1041980B1 Acyl guanidine sodium/proton exchange inhibitors and method |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/23/2005 | CN1190431C Production method of (Per-rac) alpha-tocopherol |
| 02/23/2005 | CN1190430C Process of supercritical carbon dioxide extracting licoflavone |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858645 Prevention or the treatment of CNS disorders and related medical disturbances comprising effective amount of the salt according dissolving (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5 -carboxamide in an appropriate |
| 02/22/2005 | US6858235 Antioxidant composition and method of preparation thereof |
| 02/17/2005 | WO2005014587A1 Novel process for the preparation of 2h-chromenes |
| 02/17/2005 | WO2005014586A1 Novel process for the preparation of 2h-chromenes |
| 02/17/2005 | WO2005013970A1 Agent for improving hepatobiliary disorder |
| 02/17/2005 | WO2004074305A3 Process for the production of 2-oxa-3-one androstane derivatives |
| 02/17/2005 | WO2004037193A3 Chromones and chromone derivatives and uses thereof |
| 02/17/2005 | US20050038269 Manufacture of tocol, tocol derivatives and tocopherols |
| 02/17/2005 | US20050038105 non-peptide molecules, comprising side chains of amino acids, capable of adopting a helicoidal structure independent of the primary structure of the molecules; mimics active natural helices |
| 02/17/2005 | US20050037997 Detoxification; hydrolases or esterases; short half-life; non-insulin dependent diabetes; side effect reduction |
| 02/17/2005 | US20050037099 Such as isoflavones, phytoestrogens, sitosterols and saponins from soy for use in a dermatological or cosmetic preparation; hydrolysis in acidic solution, adding water to precipitate, followed by solvent extraction steps in alcohol and organic solvent |
| 02/17/2005 | US20050037095 Compositions enriched in anthocyanins |
| 02/16/2005 | EP1506184A2 Process for the preparation of 3-isochromanone |
| 02/16/2005 | EP1246814B1 Compounds and methods for modulation of estrogen receptors |
| 02/16/2005 | CN1582159A Preparing material of flavanol wood lipid with increased solubility |
| 02/16/2005 | CN1580064A Tangeritin extracting technique |
| 02/16/2005 | CN1580052A Method for preparing anthocyanidin |
| 02/16/2005 | CN1580051A Chrysin-6-sulfonic tetranuclear calcium coordination compound, and its preparing method and use of photoluminescence property |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855833 Methods for producing amino substituted chromanes and intermediates thereof |
| 02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 02/10/2005 | US20050032881 Novel non-psychotropic cannabinoids |
| 02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
| 02/10/2005 | US20050032176 Modular polyketide synthases with altered activity |
| 02/10/2005 | CA2533102A1 Method for characterising polypeptides by maldi-tof mas spectrometry |
| 02/09/2005 | EP1504754A1 Gallocatechin gallate-containing composition |
| 02/09/2005 | EP1504000A1 4-thio coumarins |
| 02/09/2005 | EP1503752A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy |
| 02/09/2005 | EP1503751A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 02/09/2005 | EP1420802A4 Increased solubility flavanolignan preparations |